IL-2 (CD25-binding site blocker)
Assets acting on this target.
- Class
- Anti-IL-2 antibody that blocks IL-2 binding to CD25 and redirects IL-2 toward effector T cells and NK cells
Related mechanisms
GABA-A receptor (benzodiazepine site) (2)Beta-tubulin (colchicine-site-adjacent binding site) / GEF-H1 (1)IL-2 receptor subunits CD25 (IL2RA) and CD122 (IL2RB) (1)NMDA receptor (glycine site, antagonist) (1)NMDA receptor (glycine site) + dopamine/5-HT receptor (1)Vascular injury site glycocalyx / coagulation cascade (1)